Madrigal pharmaceuticals announces additions to its leadership team

Conshohocken, pa., jan. 29, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today announced three new members of its leadership team: mark barrett joins madrigal as chief business officer, clint wallace joins as chief human resources officer and tina ventura joins as chief investor relations officer.
MDGL Ratings Summary
MDGL Quant Ranking